Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Resuscitation. 2018 Oct 3;133:101–107. doi: 10.1016/j.resuscitation.2018.09.011

Table 1-.

Demographics by Treatment

Treatment Assigned
 Hypothermia
(N = 321)
Normothermia
(N = 303)
 P-value

Age at Randomization (years) 0.0721
 N 321 303
 Median [Q1 - Q3] 1.7 [0.4 - 7.6] 1.2 [0.3 - 6.5]
Age Group at Randomization 0.5092
 < 2 years 173 (53.9%) 177 (58.4%)
 2-11 years 96 (29.9%) 80 (26.4%)
 >= 12 years 52 (16.2%) 46 (15.2%)
Male 199 (62.0%) 193 (63.7%) 0.6602
Pre-existing Conditions
 No pre-existing condition 94 (29.3%) 88 (29.0%) 0.9472
 Lung or airway disease 87 (27.1%) 89 (29.4%) 0.5292
 Neurologic condition 87 (27.1%) 67 (22.1%) 0.1482
 Gastrointestinal disorder 69 (21.5%) 72 (23.8%) 0.4992
 Prenatal condition 59 (18.4%) 64 (21.1%) 0.3892
 Congenital heart disease 111 (34.6%) 112 (37.0%) 0.5352
 Other pre-existing condition 46 (14.3%) 53 (17.5%) 0.2802
Primary aetiology of cardiac arrest 0.6632
 Cardiac 99 (30.8%) 91 (30.0%)
 Respiratory 156 (48.6%) 157 (51.8%)
 Other/Unknown 66 (20.6%) 55 (18.2%)
Initial rhythm noted by EMS or hospital 0.9032
 Asystole 99 (30.8%) 97 (32.0%)
 Bradycardia 104 (32.4%) 104 (34.3%)
 Pulseless electrical activity (PEA) 58 (18.1%) 54 (17.8%)
 Ventricular fibrillation or tachycardia 31 (9.7%) 26 (8.6%)
 Unknown 29 (9.0%) 22 (7.3%)
Estimated duration of chest compressions 0.1331
 N 312 300
 Median [Q1 - Q3] 24.5 [10.5 - 40.0] 25.5 [12.5 - 48.0]
Time of ROSC 0.9612
 Day 222 (69.2%) 209 (69.0%)
 Night 99 (30.8%) 94 (31.0%)
Day of ROSC 0.6982
 Weekday 248 (77.3%) 238 (78.5%)
 Weekend 73 (22.7%) 65 (21.5%)
Total known adrenaline (epinephrine) doses3 0.3371
 N 320 302
 Median [Q1 - Q3] 3.0 [2.0 - 6.0] 4.0 [2.0 - 7.0]
ECMO4 87 (27.1%) 97 (32.0%) 0.1792

1

P-value is based on the Wilcoxon rank-sum test.

2

Chi-squared test of no association.

3

Administered by EMS and at hospital.

4

Started at or before treatment and not stopped before treatment initiation.